Mouse AdMSCs Isolation and TGF-β1/Rosiglitazone Treatment
Corresponding Organization :
Other organizations : Brigham and Women's Hospital, Harvard University, Peking University Shenzhen Hospital, Hong Kong University of Science and Technology, University of Hong Kong - Shenzhen Hospital, Rutgers, The State University of New Jersey, Broad Institute, Boston Children's Hospital, Massachusetts General Hospital, Memorial Sloan Kettering Cancer Center, Joslin Diabetes Center
Variable analysis
- Treatment with recombinant TGF-β1 (10 ng/mL)
- Treatment with rosiglitazone (10 μM)
- Outcomes of AdMSCs (not explicitly mentioned)
- AdMSCs from adult male C57BL/6J mice's inguinal fat pads
- Culturing AdMSCs in DMEM/F12 supplemented with 10% fetal bovine serum and antibiotics
- Maintaining AdMSCs at 37°C under a 5% CO2 atmosphere
- Untreated AdMSCs (negative control)
Annotations
Based on most similar protocols
As authors may omit details in methods from publication, our AI will look for missing critical information across the 5 most similar protocols.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!